Nanofiltration removal of pharmaceutically active compounds

1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Capability of nanofiltration membranes (NF) to remove pharmaceutical active compounds from wastewater streams was investigated. Sulfamethoxazole, diclofenac sodium, hydrochlorothiazide, 4-acetamidoantipyrine, nicotine and ranitinide hydrochloride were selected as model compounds since they are widely produced as pharmaceutical agents. Two commercially available polyamide nanofiltration membranes (NF-90 and NF-270 from Dow FilmTec) were tested. Solute retention by NF-90 membrane was very high in all cases (over 95%), whereas NF-270 retention systematically appeared lower ranging from 75% (nicotine) to 95% (ranitidine hydrochloride). Temporal evolution of flux decline was also investigated. The influence of physicochemical properties of both membrane and solutes on membrane performance was analyzed to explore the main solute-membrane interactions that determine the solute transfer across the membrane. The influence of operation pressure on NF-90 and NF-270 rejection was also studied. © 2012 Desalination Publications. All rights reserved.

Cite

CITATION STYLE

APA

López-Muñoz, M. J., Sotto, A., & Arsuaga, J. M. (2012). Nanofiltration removal of pharmaceutically active compounds. Desalination and Water Treatment, 42(1–3), 138–143. https://doi.org/10.5004/dwt.2012.2473

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free